positiveSYS.SOURCE: WashU Medicine• 2026-08-24T06:30:07Z
FDA Approves Blood Test for Alzheimer's Disease Biomarker Detection
The FDA has approved a blood test developed at Washington University School of Medicine for detecting Alzheimer's disease biomarkers with over 90% accuracy using high-resolution mass spectrometry. This innovation offers a less invasive alternative to traditional diagnostic methods and supports earlier treatment initiation.
*** END OF TRANSMISSION ***